Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Jessica KlusekDepartment of Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.ORCID 0000-0002-2818-0344
Jillian GiermanDepartment of Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.ORCID 0009-0006-8981-2786
Amanda J FairchildDepartment of Psychology, University of South Carolina, Columbia, SC, USA.
Andreana M BenitezDepartment of Neurology, Medical University of South Carolina, Charleston, SC, USA.
Elizabeth Berry-KravisDepartment of Pediatrics, Neurological Sciences and Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, USA.
Marsha R MailickWaisman Center, University of Wisconsin-Madison, Madison, WI, USA.
Funding
Preclinical CoreU54HD079124 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MOY, SHERYL S · 2013 to 2019
$8.0M
Translation of the FMR1 Premutation Phenotypes Across the LifespanP50HD118708 · NICHD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI Jane E Roberts · 2025 to 2026
$3.9M
Aging Symptom Trajectories in Mother Carriers of the FMR1 PremutationR01AG073374 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI Jessica Klusek · 2022 to 2026
$3.4M
Defining the Language Phenotype of the FMR1 PremutationR21DC017804 · NIDCD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KLUSEK, JESSICA · 2019 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Cognitive dysfunction in women with the · full record | Socratic